Speech-Language Pathologists in Orion, IL Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Emalee Cristina Lynn Clayton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 14th Ave, Orion, IL 61273 Phone: 309-526-3386 |
Kelly Debaillie, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 14th Ave, Orion, IL 61273 Phone: 309-526-3386 Fax: 309-526-8864 |
Tia Rondeau Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 14th Ave, Orion, IL 61273 Phone: 309-526-3386 |
News Archive
News outlets examine challenges with expanding global child immunization campaigns
Wednesday's release of the WHO, UNICEF and the World Bank joint report on childhood vaccines highlighted gains in recent global vaccination campaigns and also found that nearly 24 million infants worldwide don't get the recommended first-year vaccination.
Vaccinex completes VX15/2503 Phase 1 clinical trial in patients with advanced, refractory solid tumors
Vaccinex, Inc. today announced the successful completion of a multicenter Phase 1, multiple ascending dose clinical trial of VX15/2503 anti-Semaphorin 4D (SEMA4D) antibody in 42 adult patients with advanced, refractory solid tumors.
New procedure allows kidney transplants from incompatible donors
Researchers have found a way to stop patients rejecting kidneys that have come from incompatible donors, potentially slashing the waiting time for thousands of people in desperate need of the procedure.
Vanadium may help prepare the body to recover speedily from infections
Dietary supplements containing vanadium are used by body builders to help beef up muscles and by some diabetic people to control blood sugar. New research now suggests the naturally occurring but easily toxic element may help prepare the body to recover speedily from infections from gram-negative organisms such as E. coli.
Everolimus-eluting stent and SES are equally effective for PCI patients
The second generation drug-eluting stent, everolimus-eluting stent (EES), has consistently demonstrated superior clinical outcomes in randomised controlled trials over the first generation drug-eluting stent, paclitaxel-eluting stent.
› Verified 6 days ago